Hypofractionated Radiotherapy Combined With PD-1 Inhibitor Sequential GM-CSF and IL-2 for the Treatment of Advanced Refractory Solid Tumors (PRaG2.0)
Clinical trial NCT04892498 · UNKNOWN
Trial details
- NCT number
- NCT04892498
- Sponsor
- Second Affiliated Hospital of Soochow University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-30
- Primary completion
- 2023-08-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.